3-Hydroxyphencyclidine (3-HPC), a metabolite of phencyclidine (PCP), is increasingly attracting clinical scrutiny due to initial evidence suggesting different physiological characteristics. Present research demonstrate that 3-HPC may possess independent responses on the nervous nervous system, possibly playing a role to some of the unexplained symp